Management of relapsing–remitting multiple sclerosis in Qatar: an expert consensus
Current Medical Research and Opinion pp 1-10; doi:10.1080/03007995.2019.1669378
Abstract: Healthcare systems vary greatly between countries. International, evidence-based guidelines for the management of multiple sclerosis (MS) may need to be adapted for use in particular countries. Two years ago, the authors published a comprehensive consensus guideline for the management of MS in Qatar. Since that time, the availability of disease-modifying treatments for relapsing-remitting MS (RRMS), and our understanding of how to apply those treatments, has increased. The authors present an update to our guidance, focussing on the management of relapsing-remitting RRMS. In particular, the authors consider the optimal use of different DMTs in patients presenting with mild, medium or high disease activity.
Keywords: management / Multiple sclerosis / Qatar / Disease-modifying Therapy / immune reconstitution therapy
Click here to see the statistics on "Current Medical Research and Opinion" .